In a head-to-head trial against a full-strength GLP-1 drug, tirzepatide reduced food craving without changing measured restraint. Slower stomach emptying also makes smaller portions feel filling for longer. People whose eating was driven by stress, reward, or constant mental effort often describe the quiet as relief
The rapidness of weight loss on GLP-1 therapy can have visible costs
Peptide therapy requires physician evaluation, comprehensive laboratory testing, and ongoing clinical oversight
Most patients on GLP-1 medications should target 60 to 100 grams of protein per day, depending on body weight and activity level
Sources reviewed include: the official FeelGood website at feelgoodmeds.com, the brand's published Cancellation and Refund Policy, Terms of Use (last updated July 2025), the OpenLoop Healthcare Partners, PC telehealth consent form published at openloophealth.com, LegitScript verification data, and category-level published research on GLP-1 receptor agonists from NIDDK, NIH, and peer-reviewed clinical literature